SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:lup.lub.lu.se:e903cbb0-7ac8-4f3e-be29-4a080038e5ae"
 

Search: onr:"swepub:oai:lup.lub.lu.se:e903cbb0-7ac8-4f3e-be29-4a080038e5ae" > Consensus perspecti...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Consensus perspectives on prophylactic therapy for haemophilia: summary statement.

Berntorp, Erik (author)
Lund University,Lunds universitet,Klinisk koagulationsmedicin, Malmö,Forskargrupper vid Lunds universitet,Clinical Coagulation, Malmö,Lund University Research Groups
Astermark, Jan (author)
Lund University,Lunds universitet,Klinisk koagulationsmedicin, Malmö,Forskargrupper vid Lunds universitet,Clinical Coagulation, Malmö,Lund University Research Groups
Björkman, S (author)
show more...
Blanchette, V. S. (author)
Fischer, K. (author)
Giangrande, P. L. F. (author)
Gringeri, A. (author)
Ljung, Rolf (author)
Lund University,Lunds universitet,Enheten för pediatrisk hematologi,Forskargrupper vid Lunds universitet,Paediatric Hematologic Research Group,Lund University Research Groups
Manco-Johnson, M. J. (author)
Morfini, M. (author)
Kilcoyne, R. F. (author)
Petrini, P. (author)
Rodriguez-Merchan, E. C. (author)
Schramm, W. (author)
Shapiro, A. (author)
M Van Den Berg, H. (author)
Hart, C. (author)
show less...
 (creator_code:org_t)
2003-04-22
2003
English.
In: Haemophilia. - : Wiley. - 1351-8216. ; 9:Suppl 1, s. 41278-41278
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Participants in an international conference on prophylactic therapy for severe haemophilia developed a consensus summary of the findings and conclusions of the conference. In the consensus, participants agreed upon revised definitions for primary and secondary prophylaxis and also made recommendations concerning the need for an international system of pharmacovigilance. Considerations on starting prophylaxis, monitoring outcomes, and individualizing treatment regimens were discussed. Several research questions were identified as needing further investigation, including when to start and when to stop prophylaxis, optimal dosing and dose interval, and methods for assessment of long-term treatment effects. Such studies should include carefully defined cohorts, validated orthopaedic and quality-of-life assessment instruments, and cost-benefit analyses.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Hematologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Hematology (hsv//eng)

Publication and Content Type

art (subject category)
ref (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view